142 related articles for article (PubMed ID: 37220284)
21. Anti-TIF1γ-Dermatomyositis and Sjögren's Syndrome As the Inaugural Presentation for Rectal Cancer.
Oliveira Santos M; Santos I; Sacramento G; Oliveira R; Castanheira A
Cureus; 2024 Mar; 16(3):e55978. PubMed ID: 38618380
[TBL] [Abstract][Full Text] [Related]
22. Flare-up of dermatomyositis along with recurrence of breast cancer.
Osako T; Ito Y; Morimatsu A; Tada K; Sakurai N; Takahashi S; Akiyama F; Iwase T; Hatake K
Breast J; 2007; 13(2):200-2. PubMed ID: 17319865
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.
Mainetti C; Terziroli Beretta-Piccoli B; Selmi C
Clin Rev Allergy Immunol; 2017 Dec; 53(3):337-356. PubMed ID: 29090371
[TBL] [Abstract][Full Text] [Related]
24. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
[TBL] [Abstract][Full Text] [Related]
25. Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [(18)F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan.
Suh KJ; Park JK; Cho S; Park H; Baek HW; Lee K; Lee DS; Lee KH
Cancer Res Treat; 2016 Apr; 48(2):848-52. PubMed ID: 25797574
[TBL] [Abstract][Full Text] [Related]
26. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
[TBL] [Abstract][Full Text] [Related]
27. Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer.
Murgić J; Prpić M; Kirac I; Camino-Varela AM; Bolanca A; Kusić Z
Coll Antropol; 2012 Mar; 36(1):325-9. PubMed ID: 22816241
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies.
Okiyama N; Fujimoto M
F1000Res; 2019; 8():. PubMed ID: 31824645
[TBL] [Abstract][Full Text] [Related]
29. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous signs of classical dermatomyositis.
Auriemma M; Capo A; Meogrossi G; Amerio P
G Ital Dermatol Venereol; 2014 Oct; 149(5):505-17. PubMed ID: 25014587
[TBL] [Abstract][Full Text] [Related]
32. A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor.
Varedi D; Frigerio A; Scaife C; Hull C
Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982303
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
34. Cancer risk in dermatomyositis: a systematic review of the literature.
Di Rollo D; Abeni D; Tracanna M; Capo A; Amerio P
G Ital Dermatol Venereol; 2014 Oct; 149(5):525-37. PubMed ID: 24975953
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic dermatomyositis and prostate cancer: Myopathy regression under cancer-directed therapy.
Miranda Baleiras M; Maduro L; Vasques C; Ferreira F; Mesquita Pinto M; Martins A
Dermatol Reports; 2021 Nov; 13(3):9262. PubMed ID: 34880970
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous resolution of dermatomyositis associated with fallopian-tube carcinoma following staging surgery: A case report.
Lin C; Ying Z; Sijing C
Medicine (Baltimore); 2019 Mar; 98(10):e14530. PubMed ID: 30855437
[TBL] [Abstract][Full Text] [Related]
37. Anti-NXP2-Positive Paraneoplastic Dermatomyositis With Histopathologic Changes Confined to the Acrosyringia.
Ramírez-Bellver JL; Macías E; Bernárdez C; López-Robles J; Vegas-Sánchez MD; Díaz-Recuero JL; Quiceno H; Requena L
Am J Dermatopathol; 2017 Jan; 39(1):e3-e7. PubMed ID: 28045754
[TBL] [Abstract][Full Text] [Related]
38. Ascending Colon Cancer Associated with Dermatomyositis Which Was Cured after Colon Resection.
Kamiyama H; Niwa K; Ishiyama S; Takahashi M; Kojima Y; Goto M; Tomiki Y; Higashihara Y; Sakamoto K
Case Rep Gastroenterol; 2016; 10(2):338-43. PubMed ID: 27482193
[TBL] [Abstract][Full Text] [Related]
39. Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis.
Gono T; Kuwana M
Expert Rev Clin Immunol; 2020 Jan; 16(1):79-89. PubMed ID: 31779485
[No Abstract] [Full Text] [Related]
40. Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature.
Ono R; Kumagae T; Igasaki M; Murata T; Yoshizawa M; Kitagawa I
J Med Case Rep; 2021 Mar; 15(1):142. PubMed ID: 33745453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
